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Abstract
Background: Mansonellosis remains one of the most neglected of tropical diseases and its current distribution in
the entire forest block of southern Cameroon is unknown. In order to address this issue, we have surveyed the
distribution of Mansonella perstans in different bioecological zones and in addition, elucidated the influence of
multiple rounds of ivermectin (IVM) based mass drug administration (MDA).
Methods: A mixed design was used. Between 2000 and 2014, both cross-sectional and longitudinal surveys were
carried out in 137 communities selected from 12 health districts belonging to five main bioecological zones of the
southern part of Cameroon. The zones comprised of grassland savanna (GS), mosaic forest savanna (MFS), forested
savanna (FS), deciduous equatorial rainforest (DERF) and the dense humid equatorial rainforest (DHERF). The survey
was carried out in some areas with no treatment history as well as those currently under IVM MDA. Individuals
within the participatory communities were screened for the presence of M. perstans microfilariae (mf) in peripheral
blood by the calibrated thick film method to determine both prevalence and geometric mean intensities at the
community level.
Results: Apart from sporadic cases in savanna areas, distribution of M. perstans was strongly linked to the equatorial
rainforest zones. Before CDTI, the highest mean prevalence (70.0 %) and intensity (17,382.2 mf/ml) were obtained in
communities in Mamfes’ DHERF areas followed by communities in the DHERF zone of Lolodorf (53.8 % and 7,814.8
mf/ml, respectively). A longitudinal survey in Mamfe further showed that M. perstans infections had reduced by 34.
5 % in DERF (P < 0.001) but not DHERF zones after ten years of IVM MDA. Further data from the cross-sectional
study revealed that there was a decrease in prevalence in DHERF zones only after ten years of MDA. In DERF zones
however, the infection was relatively lower after four years of MDA.
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Conclusions: The distribution of M. perstans in the southern part of Cameroon varies with bioecological zones and
IVM MDA history. The zones with high prevalence and intensities lie in forested areas while those with low
endemicity are in the savanna areas. MDA with ivermectin induced significant reduction in the endemicity of
mansonellosis in the decidious equatorial rainforest. In contrast, the prevalence and intensity remained relatively
high and stable in the dense humid equatorial rainforest zones even after a decade of mass drug administration
with ivermectin. Since it is known that M. perstans down-regulates host's immune system, the findings from this
work would be useful in designing studies to understand the impact of M. perstans on host immune response to
vaccination and co-infection with other pathogens such as Mycobacterium spp. and Plasmodium spp. in areas of
contrasting endemicities.
Keywords: Mansonellosis, Mansonella perstans, Microfilariae, Distribution, Prevalence, Intensity, Bioecological zones,
Ivermectin, MDA, Cameroon
Background
Mansonella perstans (formerly Dipetalonema perstans)
is a vector-borne human filarial nematode, transmitted by
tiny blood-sucking midges of the genus Culicoides and is
the causative agent of mansonellosis [1]. It is one of the
most prevalent human parasites in sub-Saharan Africa
(reported in 33 countries) and over 114 million people are
infected throughout the continent [1]. On the west coast of
Africa, it spreads from Senegal to Angola, through central
Africa, north to southwest Sudan, east to Uganda, Kenya
and Tanzania and south to Zimbabwe [2]. In most affected
countries (Cameroon, Nigeria, Ghana, Sierra Leone, Ivory
Coast, Zambia and Uganda), the disease occurs mainly
among poor people living in rural villages [2, 3]. Although
absent in most northern and southern regions of Africa
and Asia, M. perstans infections are prevalent in Central
and South America as well as the Caribbean [1].
Infections with M. perstans present mild pathology
compared to infections with other filarial parasites such
as Wuchereria bancrofti, Brugia malayi, Onchocerca
volvulus and Loa loa. However, the pathogenicity of M.
perstans infection has recently been reconsidered since
Bregani et al. [4], documented that M. perstans has the
ability to induce a variety of clinical features, including
angioedema Calabar-like swellings, pruritus, fever, head-
ache, high eosinophilia, abdominal pain, arthralgia, and
neurologic manifestations. In addition, people harbour-
ing the parasite have reported bouts of itchiness and
dizziness [5] and there are reports that M. perstans is
possibly involved in the development of ocular filariasis
as well [6]. Infections with M. perstans have also been
shown to induce an immunosuppressive environment in
the host [1] through the involvement of a pleiotropic
immunomodulatory cytokine IL-10 [7, 8]. IL-10 is well
known for its ability to down regulate T helper 1-type
responses such as IFN-gamma secretion and activation
of monocytes/macrophages [9] and as such, the host
may become vulnerable to other pathogens gaining
access and invading a dampened immune system.
No specific treatment exists for mansonellosis and
ivermectin (IVM), widely used for mass drug administra-
tion (MDA) for other filariae, has been reported to have
little effect on the infection through community directed
treatment with ivermectin (CDTI) [10]. Mebendazole
has also been shown to have moderate effect on M.
perstans [11]. Although rainforest areas and warm
climates seem to favour M. perstans, a detailed know-
ledge about the environmental factors that support the
vector and may account for the differential distribution
of the disease is limited [12, 13], especially in Cameroon.
In 1995, Mommers et al. [13] provided an account of
the distribution of M. perstans in the southern part of
Cameroon; however, prevalence in entire forest block
remains unclear since repeated surveys were only
performed in a single community. Due to the relevance
of this parasite in down-regulating host immunity, we
have surveyed the distribution and prevalence of M. per-
stans infection in major bio ecological zones (grassland
savannah, mosaic forest savannah, forested savannah,
deciduous equatorial rainforest and dense humid
equatorial rainforest) in southern Cameroon. More-
over, we compared prevalence of infection in areas
before and > 10 years after IVM MDA introduction.
These datasets provide useful tools for designing
studies aimed at understanding the impact of M. per-




This study used a mixed study design (cross-sectional
and longitudinal surveys) and was carried out in 137
communities of five main bioecological zones: grassland
savannah (GS), mosaic forest savannah (MFS), forested
savannah (FS), deciduous equatorial rainforest (DERF)
and dense humid equatorial rainforest (DHERF), belong-
ing to 12 health districts of Cameroon from the year
2000 to 2014 (Fig. 1). Based on the stratification of
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health districts, communities were randomly selected as
well as households within the communities. To establish
the possible impact of IVM MDA on M. perstans distri-
bution, the health districts in different bioecological
zones were classified into three main groups. The first
group was health districts surveyed before the introduc-
tion of IVM MDA or with no treatment history at the
time of sampling. The second group was health districts
surveyed whilst IVM-MDA has been ongoing and the
third group was specific communities of health districts
(Mamfe and Nwa) surveyed before and whilst under
IVM-MDA. Figure 2 shows in detail, the current years
of IVM-MDA in each surveyed health district. In each
participatory community, eligible individuals (both males
and females) were those that had lived in the communi-
ties for at least five years and were at least five years old.
Recruited volunteers that met the eligibility criteria gave
their full written consent and for children, consent was
provided by the child's parent or legal guardian. Details
on gender and median age of individuals in the various
health districts and bioecological zones are shown in
Additional file 1: Figure S1. Each volunteer was screened
for the presence of M. perstans microfilariae in peripheral
blood. Both prevalence and geometric mean intensities
were generated with respect to communities in health
districts and statistically compared for the different
bioecological zones.
Study site
The study was carried out in communities selected from
both rainforest and savanna areas in Cameroon. The
climate varied from "Guinea type" in the South and East
bioecological zones through equatorial hot and wet in
the Littoral, to temperate in the South West and humid
savanna/tropical in the North West zones. Warm cli-
mates (guinea and temperate type) seem to favour the
transmission of M. perstans. The climate of savanna
areas are typically humid savanna to tropical forest type
and in this study we surveyed three distinct savanna
regions. GS: this includes communities of the Nkambe
health district of north-west Cameroon. This area is
mainly grassland, characterised by sparse trees that are
Fig. 1 Bioecological zones in M. perstans endemic areas in cameroon. Map shows sampling areas in relationship to bioecological zones.
FS, forest savannah; MFS, mosaic forest savannah; GS, grassland savannah; DERF, deciduous equatorial rainforest; and DHERF, dense habitat
equatorial rainforest
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widely spaced to provide an open canopy. Areas of MFS
include communities of the Kumbo health district still
in the western highlands of Cameroon. The vegetation is
mainly grassland crossed with trees growing alongside
streams and on hillsides but the tree density is less
compared to the forested savanna. FS contained commu-
nities of the Nwa health district also in the western high-
lands of Cameroon. The vegetation here is typically
grass with a very high density of trees and has a humid
climate. This FS is thus a transition between savanna
and forest zones. DERF areas comprised communities in
Bare, Tombel, Konye, Kumba and Mamfe health districts
in the littoral and south-west regions of Cameroon. This
type of forest has a warm climate and is characterised
with high rainfalls while the dry season is cooler. Also
many trees shed their leaves creating a reduction in the
canopy thus permitting sunlight to reach the forest floor
and hence growth of vigorous ground vegetation [14].
Finally, the DHERF comprised some communities of
Mamfe, Bertoua, Messamena, Batouri and Lolodorf
health districts in the south-west, south and east regions
of Cameroon. The climatic conditions remain equal here
all year round and are marked with high daily and
nightly temperatures as well as heavy daily rainfall. The
warmth and high humidity also accounts for the high
biological diversity observed in these areas. Unlike the
DERF, no leaves are shed here in the dry season, and as
such, the DHERF have a well-developed canopy "tier"
form of vegetation [14] and can be referred to as pri-
mary forests. The majority of the inhabitants of these
zones are subsistence farmers and the main cash crops
include cocoa, rubber, cassava, maize, yams, plantains
and bananas. Crops like bananas and plantains as well as
their products are cultivated near homes and serve
therefore as efficient breeding sites for Culicoides spp.
As such, the population is exposed to the bites of the
vectors through their activities.
Parasitological screening
Diagnosis of mansonellosis is through the detection and
identification of M. perstans mf in peripheral blood [15].
Samples were collected for diagnosis during the day.
Fig. 2 Rounds of mass drug administration programmes in years in M. perstans endemic areas in Cameroon. MDA rounds at the time of
sampling in 2013: white = no treatment; pale blue = 4 years; mid-blue = 8 years MDA and dark blue = >10 years. Striped areas refer to sites of
longitudinal survey where in, samples were obtained before MDA started and after either 8 (Nwa) or >10 (Mamfe) years
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Thick blood films were prepared from standardized 50 μl
finger pricked blood using 75 μl non-heparinised capillary
tubes. Smears were prepared by spreading the blood on
clean slides covering an area of 1.5 × 2.5 cm and allowed to
air-dry. In the laboratory, the blood smears were dehaemo-
globinised using tap water for 10 to 15 min and were fixed
with methanol for 1 min. Smears were later stained in 10 %
Giemsa for 45 min, rinsed in distilled water and allowed to
air-dry [3, 16]. Slides were read under a light microscope at
a magnification of 10× by trained technicians. Parasites
were identified using the mf identification keys of Orihel
et al. [17]. In study areas co-endemic for Loa loa, another
filarial species with blood dwelling mf, identification was
done by two well-trained technicians in a blind manner. Mf
counts were expressed as microfilariae per millilitre of
blood (mf/ml).
Data analysis
Statistical analyses were performed using the software SPSS
(IBM SPSS Statistics 20; Armonk, NY) and GraphPad
PRISM version 5.02 for Windows (GraphPad Software,
Inc., La Jolla, USA, www.graphpad.com). P-values of less
than 0.05 were considered statistically significant. For data
that were not normally distributed, the following tests
were performed: Kruskal-Wallis test was performed to
compare three groups, followed by a Mann-Whitney
U-tests for further pairwise comparisons. For comparisons
of continuous parameters, the Spearman rank correlation
was used. Mann-Whitney and Kruskal-Wallis tests were
used to compare mean prevalence and geometric mean
intensity of M. perstans in communities and health dis-
tricts of the different surveyed bioecological zones. Mf
prevalence and geometric mean intensities were also
compared with respect to MDA history.
Results
Absence of IVM-MDA programmes reveals a dominant M.
perstans prevalence in ERF areas
In this study, we analysed blood samples for M. perstans
infection from individuals living in savanna (n = 3,073
individuals in 26 communities) and ERF (n = 2,648 indi-
viduals in 29 communities) areas that had not yet started
ivermectin MDA programmes (Figs. 1 and 2). Figure 3a,
b shows that the prevalence of M. perstans and corre-
sponding mf intensity were significantly higher in ERF
geographical areas since very few positive persons were
detected in savanna districts (n = 3/3,073). We further
subdivided the study area into savanna zones: grassland
(GS), forest (FS) and mosaic forest (MFS), and equatorial
rainforest (ERF) zones: deciduous equatorial rainforest
(DERF) and dense humid equatorial rainforest (DHERF).
This revealed that all savanna bioecological zones (MFS,
FS and GS) were extremely low in infection whereas
both DERF and DHERF zones had high prevalence, up
to 100 % in some communities (Fig. 3c) and high mf
intensity (Fig. 3d). Further analysis on individual health
districts revealed that amongst the health districts in the
DHERF region, Mamfe had a significantly higher preva-
lence of M. perstans infection than Lolodorf or Batouri
(Fig. 3e). Significant differences in mf intensities were also
revealed upon comparison of Mamfe and Batouri DHERF
districts (Fig. 3f). No significant differences were found
between Mamfe communities residing in DERF and
DHERF areas. Thus, in the absence of any MDA pro-
grammes M. perstans infection is restricted to ERF
geographical zones. Table 1 provides details about the
prevalence and mf intensity in each surveyed community.
Mansonella perstans prevalence and intensity in areas
surveyed under MDA programmes reveal varying trends
Tables 2 and 3 show the current prevalence and intensity
in ERF and FS districts that have had multiple rounds of
IVM-MDA. With health districts surveyed under IVM-
MDA for 4 and 8 years (Table 2), the prevalence ranged
from 0.5 % in the FS of Nwa (8 years of IVM-MDA)
through 23.2 % in the DERF of Bare (4 years of IVM-
MDA) to 51.0 % in the DHERF of Messamena (8 years of
IVM MDA). The same trend was observed in the mf
geometric mean intensity. Therefore, both prevalence and
intensity of M. perstans infection were highest in the
DHERF compared to DERF and FS in communities
surveyed 4 and 8 years under IVM-MDA. Whereas, with
health districts surveyed with over a decade of treatment
(Table 3), the highest prevalence was observed in the
DERF of Mamfe (49.73 %) and the least in the DERF of
Kumba (7.9 %). The mf intensity was rather high in the
DHERF of Mamfe compared to the other health districts
(Additional file 2).
Longitudinal surveys in Mamfe reveals reduced M. perstans
infection in DERF but not DHERF zones after > 10 years
IVM-MDA
As shown in Fig. 3, in the absence of IVM-MDA M.
perstans infections were highly prevalent in ERF zones.
The district of Mamfe in the South West of Cameroon
is an ERF geographical zone and we performed a longi-
tudinal study of M. perstans infection between 2000 and
2013. Figure 4a, b provides comparative data for the
prevalence and mf counts in Mamfe before the start of
IVM-MDA (0 MDA; n = 771 individuals) and after more
than 10 years of therapy (>10 MDA; n = 615 individuals).
Data from these seven communities showed both trends
of decrease and increase, therefore we divided the
communities into those residing in DERF and DHERF
zones (Fig. 1). Interestingly, communities residing in
DERF zones (Assam, Bache, Kesham and Okpambe)
presented a decreased prevalence (Fig. 3c) and mf
intensities (Fig. 4d) whereas those in DHERF zones
(Babong, Oguarag and Nkoghau) did not (Fig. 4e, f ).
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Tables 1 and 3 show the data for each community before
and after IVM-MDA treatment. Table 4 shows the
percentage reduction in both prevalence and mf inten-
sity of M. perstans in the communities of Mamfe in
DERF and DHERF zones. In Fig. 3e, f we have also
shown that the FS geographical zone Nwa had very low
M. perstans infection prior to MDA (0.2 %) and in 2013,
after > 8 years of MDA only 6/1,329 individuals were
found microfilaraemic (Additional file 2: Figure S2; Add-
itional file 3 Table S1). These data reveal two important
situations: (i) FS zones contain little M. perstans and this
has not changed before or after MDA treatment; and (ii)
IVM treatment appears to have an effect on M. perstans
infections in DERF but not DHERF zones (Additional
file 2: Figure S2; Additional file 3 Table S1).
Comparisons of DHERF communities following multiple
MDA rounds reveals reduced prevalence in the south-
western but not eastern Cameroon
Since M. perstans prevalence and intensities were different
in DERF vs DHERF communities in Mamfe (Fig. 4), we




Fig. 3 M. perstans infections are prevalent in ERF but not savanna areas. To determine the baseline prevalence (a) and intensity (b) of M. perstans
infection prior to MDA in South West and eastern districts of Cameroon, individuals were screened in savannah (n = 3,073) and ERF (n = 2,648) zones
that were yet to begin MDA programmes. Prevalence (c) and associated mf counts (d) were then assessed in GS, MFS and FS savannah districts and
DERF and DHERF forest districts. Data were then further examined on an individual district level: Nkambe, GS (8 communities/n = 1,167); Kumbo, MFS
(8 communities/n = 878); Mamfe, DERF (7 communities/n = 818) and DHERF (9 communities/n = 640); Lolodorf, DHERF (4 communities/n = 290),
Batouri, DHERF (9 communities/n = 900); Nwa, FS (10 communities/n = 1,028). Statistical significance of the differences between groups indicated by
the brackets were obtained after ANOVA/Kruskal-Wallis or Student's t-test or Mann-Whitney analysis depending on the normal distribution of the data
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Table 1 M. perstans prevalence and intensity in five bioecological zones surveyed without any treatment history
Ecological zone Health district/year of survey Community Number surveyed Number positive Prevalence (%) Geometric mean (mf/ml)
Bansobi 195 0 0 0
Dzeng 186 0 0 0
Kifem I 151 0 0 0
GS Nkambe/2000 Lam 140 0 0 0
Njanawa 105 0 0 0
Rifem 212 0 0 0
Tanyar 52 0 0 0
Yang 126 0 0 0
Total 1,167 0 0 0
Bem 119 0 0 0
Chunghe 78 0 0 0
Kamine 125 0 0 0
Kibbo 94 1 1.06 2,072.8
MFS Kumbo/2000 Lip 133 0 0 0
Mbissa 115 0 0 0
Mfume 68 0 0 0
Nkanchi 146 0 0 0
Total 878 1 0.11 2,072.8
Jator 111 0 0.0 0
Mbiripkwa 70 0 0.0 0
Ngomkow 66 0 0.0 0
Ngu 112 1 0.9 13.90
Nguri 90 0 0.0 0
FS Nwa/2000 Nking 96 0 0.0 0
Ntem 95 0 0.0 0
Nwanti 107 0 0.0 0
Nwat 52 0 0.0 0
Sabongari 229 1 0.4 13.90
Total 1,028 2 0.2 13.90
Assam 57 52 91.2 10,402.8
Bache 128 70 54.7 1,539.0
Kesham 174 104 59.8 1,543.6
DERF Mamfe/2000 Obonyi 1 121 94 77.7 1,2577.0
Obonyi-3 159 119 74.8 4,036.1
Okpambe 45 35 77.8 8,743.4
Takamanda 134 94 70.1 4,427.3
Total 818 568 69.4 4,344.7
Ajaman 88 76 86.4 91,380.1
Akwa 66 57 86.4 40,762.6
Araru 30 21 70.0 2,199.2
Babi 26 26 100.0 31,180.4
DHERF Mamfe/2000 Babong 181 95 52.5 2,735.4
Ekoneman 24 14 58.3 12,749.6
Mbofong 39 36 92.3 94,757.9
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DHERF areas that had had zero (Lolodorf and
Batouri), 8 (Messemena and Bertoua) or > 10 rounds
of MDA (Mamfe). Interestingly, prevalence and intensities
were not significantly altered between 0 or 8 rounds of
MDA but after more than 10 years, M. perstans infection
rates were significantly reduced (Fig. 5a, b). To rule out that
the observed reduction in Mamfe after 10 years was not
due to simply lower prevalence to begin with, we also
compared Mamfe levels prior to MDA and here, prevalence
and mf levels were significantly higher than in 2013
(Fig. 5b, c). Moreover, prevalence rates in "Mamfe 0"
were also significantly higher than in Lolodorf, Batouri
and Messamena as well (Fig. 5b, P < 0.001). With regards
to mf levels however, only individuals in Lolodorf
showed significantly more mf/ml than those in Mamfe
(Fig. 5d, P < 0.001) (Additional file 2).
Communities within DERF zones show lower prevalence
and intensity after multiple IVM-MDA rounds
As depicted in Fig. 1, Mamfe can be divided into DERF
and DHERF zones. Since M. perstans prevalence and
intensity had decreased in the DHERF Mamfe health
district after > 10 years of IVM-MDA (Fig. 5a, c), we
further compared the effects of > 10 years IVM-MDA
on M. perstans in communities in DERF zones. Here,
communities in Mamfe (n = 4), Tombel (n = 14), Kumba
(n = 18) and Konye (n = 10) were compared. Interest-
ingly, the highest prevalence of M. perstans was found
in individuals living in Mamfe (Fig. 6a) and mf
intensities were also significantly higher when com-
pared to Konye and Kumba (Fig. 6b, P <0.001). Preva-
lence rates in communities within Tombel were also
significantly higher than those from Konye and Kumba
(Fig. 6a, P < 0.001) which was further reflected in mf in-
tensities (Fig. 6b). Table 3 shows a detailed overview of
each community. In our final analysis, we compared
DERF communities that had had 0, 4 and > 10 years of
IVM-MDA. Table 2 provides details about the health
district Bare, which at the time of sampling had only
participated in IVM-MDA for 4 years. Figure 6c, d
shows that in comparison to communities that had re-
ceived no IVM-MDA (n = 818 individuals, Table 1), both
prevalence and intensity levels were lower in communities
that had received 4 years of IVM MDA (n = 872 individ-
uals, Table 2) and > 10 years of IVM-MDA (n = 3,672 indi-
viduals, Table 3). Thus, in confirmation of the longitudinal
study shown in Fig. 4c, there is a general decrease in M.
perstans prevalence and intensity in communities within
DERF zones that have received 4–10 years of IVM-MDA
(Additional file 3 Table S1).
Discussion
The overall objective of this study was to provide a
comprehensive overview about the current distribution
of M. perstans in Cameroon, taking into consideration
the advent of ivermectin MDA. Therefore, using a
sample of 14,293 individuals from 137 communities, we
determined the prevalence and intensity of M. perstans
Table 1 M. perstans prevalence and intensity in five bioecological zones surveyed without any treatment history (Continued)
Nkoghau 107 63 58.9 11,391.1
Ogurang 79 60 75.9 8,699.7
Total 640 448 70.0 17,382.9
Dem2 115 27 23.5 348.2
Djal 114 30 26.3 1,380.9
Kamba Mieri 126 19 15.1 811.6
Konga 149 105 70.5 3,930.3
DHERF Batouri/2013 Gabaleta 47 6 12.8 899.4
Ngoulmekong 96 52 54.2 2,334.0
Nguikouassima 63 20 31.7 589.1
Baktala 110 53 48.2 1,226.7
Bouam 80 38 47.5 4,573.6
Total 900 350 38.9 1,947.7
Bibondi 100 55 55.0 4,296.8
DHERF Lolodorf/2010 Bikalla 94 65 69.1 19,797.5
Bikoka 30 11 36.7 1,049.4
Ngovayang 66 25 37.9 4,905.5
Total 290 156 53.8 7,814.8
Abbreviations: GS grassland savanna, MFS mosaic forest savanna, FS forested savanna, DERF deciduous equatorial rainforest, DHERF dense humid equatorial
rainforest, mf/ml M. perstans microfilariae per millilitre of blood
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Table 2 Prevalence and mean mf intensity of M. perstans in zones under CDTI for 4–8 years (Bare, Bertoua, Messamena and Nwa)
Ecological zone Health district/year
of survey
CDTI Status Community Number examined Number positive Prevalence (%) Geometric mean
(mf/ml)
Mandjibo 67 11 16.4 209.6
Mbarembeng I 95 4 4.2 62.6
Mbarembeng II 72 3 4.2 29.2
Mbie 27 12 44.4 502.6
4 years Mounko 67 3 4.5 85.6
DERF Bare/2010 Mpaka 73 1 1.4 13.9
Ndom 103 36 35.0 1,410.3
Ndouembot 22 17 77.3 15,322.1
Ndouenke 29 21 72.4 7,965.2
Nkoniambot 174 51 29.3 314.9
Nkoniankoniama 19 14 73.7 3,546.0
Nkounianke 124 29 23.4 912.5
Total 872 202 23.2 1,116.7
Bombi 112 82 73.2 4,162.3
Deng-Deng 105 40 38.1 3,354.1
DHERF Bertoua/2013 8 years Kanda 126 33 26.2 5,341.8
Mbethen 2 112 86 76.8 3,193.2
Ndemba 1 106 40 37.7 767.8
Total 561 281 50.1 3,062.6
Aviation 114 22 19.3 222.5
Bissoua 2 155 107 69.0 3,758.8
Doume Village 42 10 23.8 209.4
Koum 45 26 57.8 898.4
Labba 34 27 79.4 9,189.4
DHERF Messamena/2013 8 years Mayos 74 39 52.7 1,757.1
Meba 47 35 74.5 2,532.2
Messamena Village 78 46 59.0 5,275.1
Nkomzuh 58 31 53.4 1,180.3
Ntollock 52 14 26.9 75.9
Soleye 163 83 50.9 1,976.9
Total 862 440 51.0 2,115.8
Jator 115 2 1.7 150.0
Mbiripkwa 137 0 0 0
Ngomkow 156 1 0.6 316.0
Ngu 143 0 0 0
FS Nwa/2013 8 years Nguri 143 0 0 0
Nking 108 0 0 0
Ntem 153 0 0 0
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in five major bioecological zones of Cameroon. We
observed that in the absence of MDA programmes, the
highest prevalence of mansonellosis was restricted to
equatorial rainforest areas since all three different
savanna areas had only sporadic infection cases. Indeed,
from 3,073 samples from savanna areas, only three
individuals in Nkambe (GS), Kumbo (MFS) and Nwa
(FS) were microfilaraemic. In contrast, M perstans was
extremely prevalent in communities within DHERF and
DERF zones with 20/29 communities showing preva-
lence over 50 %, 12/29 communities over 70 % and 3/29
communities over 90 %. Not a single community was
found negative in the forest area. The lowest prevalence
(12.8 %) was observed at Gabaleta in Batouri. The
geometric mean of mf was also high reaching an average
of 91,380.1 and 94,757.9 mf/ml in individuals in Ajaman
and Mbofong, respectively, in Mamfe (DHERF). These
data show that although M. perstans in Cameroon is
widespread this species is largely restricted to ERF zones
in which there can be hotspots of intensity. These results
correlate with the observations of Akue et al. [18] in
Gabon who also found that M. perstans was significantly
higher in forest ecosystems than in savannas and lake
land areas. Other studies have reported varying levels of
M. perstans infection. For example, Noireau et al.
reported a prevalence of 22 % in the forest regions of
the Chaillu mountains in the Congo [19] and a preva-
lence of 26.6 % was observed in a community in the
dense forest of southern Cameroon [13] but only 12.4 %
of inhabitants in the forested Akonolinga health dis-
trict of Central Cameroon were found to be M. per-
stans-positive [20]. Our findings of higher prevalence
are more in-line with the studies from Asio et al. [21]
who reported prevalence of up to 80 % in endemic
communities of Uganda.
Cross-sectional surveys in communities of the study
districts under treatment showed that although they had
received varying rounds of IVM, a higher prevalence was
still observed in DERF and DHERF compared to FS. The
higher prevalence of M. perstans infection in forest areas
(Mamfe, Messamena, Bertoua, Batouri, Lolodorf and
some areas of Bare health districts) reflects the environ-
mental conditions desired by the Culicoides spp. vectors.
In contrast to GS and MFS areas, the DHERF and DERF
zones provide ideal breeding conditions for the vectors.
These include a warmer climate, sufficient rainfall and
appropriate habitats such as fallen leaves, decaying plan-
tains and banana stems. Moreover, these breeding sites
are close to the hosts' dwellings providing an opportunity
for parasite transmission. However, it can also not be ruled
out that the species of Culicoides responsible for transmit-
ting M. perstans is simply just refined to DHERF and
DERF zones. Parallel entomology surveys were not per-
formed with these surveys but future studies should con-
centrate on identifying the Culicoides spp. in those areas.
The intensity of infection as expressed by the geomet-
ric mean of microfilarial load varied across communities
of the surveyed health districts. In the no treatment area,
the mean ranged from 0 mf/ml in the GS of Nkambe
health district through 13.9 mf/ml in the FS of Nwa to
17,382.2 mf/ml in the DHERF of Mamfe and closely
followed by the DHERF of Lolodorf with 7,814.8 mf/ml.
The same trend was observed with the prevalence in
these areas. Moving across the five bioecological zones,
the intensity increased from GS, through MFS (mosaic
forest savanna) and FS to DERF and DHERF. Neverthe-
less, the high intensities in the DHERF before IVM
MDA still emphasize the conserved nature of this eco-
logical zone, making transmission very possible between
the human host and the competent vector. A limitation
of this study included the use of thick blood smears for
M. perstans diagnosis which may have missed low mf
counts. This diagnostic tool was employed so that all
samplings from different time periods could be compared
with another.
In the health districts under IVM MDA, the highest
mean intensity (3,062.6 mf/ml) was observed in the
DHERF of Bertoua with 8 years of ivermectin MDA and
the lowest (175.8 mf/ml) in the FS of Nwa with equally
8 years of IVM MDA. The health districts under control
for over 10 years had relatively lower intensities com-
pared to those of 4 and 8 years. The decreasing trend in
intensity observed over time in these bioecological zones
with an increase in the number of rounds of IVM con-
sumed is indicative that this drug has partial effect on
M. perstans in the human host, although some authors
have shown that the drug has no effect on the parasite
[14, 20]. The varying intensity and prevalence in our
Table 2 Prevalence and mean mf intensity of M. perstans in zones under CDTI for 4–8 years (Bare, Bertoua, Messamena and Nwa)
(Continued)
Nwanti 140 1 0.7 111.4
Nwat 124 1 0.8 13.9
Sabongari 110 1 0.9 1,509.8
TOTAL 1329 6 0.5 175.8
Abbreviations: GS grassland savanna, MFS mosaic forest savanna, FS forested savanna, DERF deciduous equatorial rainforest, DHERF dense humid equatorial
rainforest, mf/ml M. perstans microfilariae per millilitre of blood
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Table 3 Prevalence and mean mf intensity of M. perstans in the DERF and DHERF surveyed after over a decade under CDTI (Mamfe,
Konye, Kumba and Tombel health districts)
Ecological zone Health district/year
of survey
CDTI status Community Number examined Number positive Prevalence (%) Geometric mean
(mf/ml)
Assam 59 40 67.80 4,763.3
DERF Mamfe (2010 & 2013) >10 years Bache 104 47 45.20 1,146.1
Kesham 126 55 43.7 972.5
Okpambe 87 45 51.70 3,173.6
Total 376 187 49.73 1,934.8
Afap 26 5 19.20 21.8
Ayukaba 116 12 10.34 1,128.1
Babong 93 68 73.11 4,971.1
Bokwa 60 20 33.33 274.3
Ebam 95 2 2.11 801.3
Eshobi 90 36 40.0 1,154.9
DHERF Mamfe (2010 & 2013) >10 years Eyanchang 113 1 0.97 4,161.2
Kajifu 100 22 22.0 3,101.8
Mbakem 40 4 10.0 508.7
Mbatop 115 9 7.83 299.7
Mbeme 85 17 20.0 1,149.3
Momboh 88 9 10.22 112.2
Nkoghau 60 38 63.33 1,795.4
Nyang 32 22 68.75 7,976.6
Ogurang 86 66 76.74 12,170.2
Taboh 77 11 14.30 73.1
Total 1276 342 26.80 2,445.1
Baduma 84 7 8.3 369.3
Bakolle 78 5 6.4 155.7
Bolo 107 11 10.3 165.6
Dikomi Bafaw 101 12 11.9 72.6
Eboko Bajor 89 10 11.2 216.7
DERF Konye (2010 & 2013) >10 years Kokaka 74 14 35.1 122.1
Kombone 97 11 11.3 204.3
Kurume 45 5 11.1 86.0
Matondo 107 5 4.7 206.9
Weme 103 17 16.5 385.6
Total 885 97 11.0 183.2
Bai Bikom 91 0 0 0
Bai Manya 89 2 2.2 150.0
Bai Panya 43 0 0 0
Bakumba 76 11 14.5 971.0
Bambele 66 11 16.7 377.0
Big Massaka 157 7 4.5 2,234.2
Bikoki 46 30 65.2 1,077.6
Boa Bakundu 60 6 10 451.7
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study participants show that bio-ecology plays a defining
role in the distribution of M. perstans even without the
influence of ivermectin. To elucidate the effect of IVM-
MDA on M. perstans, we performed a longitudinal sur-
vey using data from 7 communities in Mamfe (screened
at 0 MDA and > 10 years IVM-MDA) as a case study.
Our initial conclusion was that long-term IVM-MDA in
the communities was having little effect on M. perstans
infection since study sites showed both trends of
increase and decrease. However, further analysis revealed
that although the overall prevalence was not significantly
reduced in the DERF communities (P = 0.335), the
decrease in intensity over 10 years of MDA was signifi-
cant (P < 0.001 and a 34.58 % reduction). This trend was
not reflected in the DHERF communities of Mamfe
since the prevalence either remained stagnant or had
increased over time. Interestingly, mf levels in Nkoghau
were drastically reduced after > 10 years MDA (11,391.1
vs 1,795.4 mf/ml) even though the prevalence were
comparable (58.9 vs 63.3 %). Overall, our data indicate
that in DERF communities of Mamfe, transmission is
reduced due to either a loss of primary forest and thus
breeding sites for the vector, due to impact of IVM,
which needs at least 10 years to take effect, or possibly a
lowered infection rate in the host. Since the reduction in
M. perstans was not observed after long-term MDA in
DHERF communities of Mamfe, the effects are more
likely to be a consequence of habitat destruction. Studies
relating M. perstans infection and IVM-MDA have shown
contrasting outcomes. For example, Kyelem et al. [22]
demonstrated that after multiple rounds of IVM-MDA in
south-western Burkina Faso (Dano area), a significant
reduction in M. perstans and Wuchereria bancrofti mf
was seen in ivermectin-treated communities. However, a
follow-up study by the same authors reported that long
term administration (14 years) of IVM-MDA in Burkina
Faso (Dienkoa) had no effects on M. perstans [23]. Of
interest, this latter study was performed in a savanna
Table 3 Prevalence and mean mf intensity of M. perstans in the DERF and DHERF surveyed after over a decade under CDTI (Mamfe,
Konye, Kumba and Tombel health districts) (Continued)
DERF Kumba (2010 & 2013) >10 years Bobanda 32 4 12.5 1,651.5
Ediki 101 8 7.9 85.9
Kotto Barombi 66 0 0 0
Kumu-Kumu 34 11 32.4 418.8
Marumba I 50 0 0 0
Marumba II 68 0 0 0
Mbalangi 100 2 2.0 359.1
New Town 96 3 3.1 316.0
Pete Bakundu 34 0 0 0
Small Massaka 33 3 9.1 1,586.6
Total 1241 98 7.9 667.7
Bulutu 86 17 19.8 148.2
Ehom 74 6 8.1 70.8
Kack 142 28 19.7 337.5
Mbabe 68 20 29.4 2,610.1
Mbule 73 37 50.7 2,110.6
Mile 18 54 6 11.1 279.5
DERF Tombel (2010 & 2014) >10 years Mpako 1 63 21 33.3 1,052.8
Ndom 67 18 26.9 609.2
Ngab 53 14 26.4 392.9
Ngusi 102 11 10.8 2,452.9
Nlog 107 38 35.5 4,003.6
Nsuke 113 18 15.9 1,646.2
Peng 81 22 27.2 616.8
Ndabekom 87 25 28.7 1,321.1
Total 1,170 281 24.0 1,081.0
Abbreviations: GS grassland savanna, MFS mosaic forest savanna, FS forested savanna, DERF deciduous equatorial rainforest, DHERF dense humid equatorial
rainforest, mf/ml M. perstans microfilariae per millilitre of blood
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("Guinea" type) bioecological zone and there, prevalence
of M. perstans infection (0–10.9 %) was higher than those
reported in the present study (0–1.06 %) [23]. Research by
other teams in Togo and Uganda [24, 25] have also not
confirmed the trend of reduced infection rates in M.
perstans following IVM seen by Kyelem et al. [22]. These
studies were conducted in the early 90's and therefore
only a few rounds of IVM treatment would have occurred
since CDTI only commenced in 1995. Fischer et al. [24]
reported that after IVM intake, prevalence rates were
comparable but no data on mf intensity were provided.
The study in Uganda [24] followed mf counts during a six
month period after IVM administration and noted that
prevalence rates remained the same but mf counts
dropped by approximately 40 % within the first two weeks
of treatment. Interestingly however, mf counts then stabi-
lised and, since it remains unclear whether M. perstans




Fig. 4 Longitudinal surveys in Mamfe reveal dampened M. perstans infection in DERF but not DHERF zones after >10 years MDA. a Prevalence
and b mf intensity in Mamfe district (7 communities) prior to IVM therapy (0 MDA; n = 771) and after at least 10 years of MDA treatment (>10 MDA;
n = 615). Analysis of individuals in DERF located communities of Mamfe (Assam, Bache, Kesham and Okpambe) revealed reduced prevalence and mf
intensity c and d respectively): 0 MDA; n = 404 and > 10 MDA; n = 376. Infection in individuals of the DHERF communities of Mamfe (Babong, Ogurang
and Nkoghau) remained unchanged or trended upwards (e and f): 0 MDA; n = 367 and > 10 MDA; n = 239. Symbols at each time point represent
mean prevalence (%) or mf intensity (mf/ml) from one community
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whether mf are destroyed or eliminated [25]; this is an
element that has to be factored into our findings as well.
Furthermore, some of these studies were monitored in
individuals co-infected with other filariae or in endemic
areas for other filariae [22–25] and since IVM kills mf of
both Onchocerca volvulus and W. bancrofti, immune
responses to those dying mf may have some overlapping
effects on M. perstans mf. In addition, studies have shown
that M. perstans infections down-regulate the host's
immune system through the involvement of IL-10 which
may facilitate infections to other incoming pathogens
[7, 8, 12]. Studies have investigated the impact of
filarial infections on coincident intracellular pathogens
and demonstrated the interplay between filarial para-
site and microbial pathogen, but the influence of the
interplay on disease outcome remains unclear [26].
Unlike other filarial infections, infection with M. perstans
begins at childhood and the intensity increases with age
[5, 27]. We therefore hypothesise that in areas of high M.
pertans transmission, the immune response in children
infected could be downregulated with negative conse-
quences on the mounting of strong immune responses
during childhood vaccinations and to control coincident
pathogens. The present study has delineated the endem-
icity of M. perstans in the forest block of Cameroon and
demonstrated that the ecology that favours the vector is of
Table 4 Percentage reduction in M. perstans prevalence and intensity in selected communities of Mamfe and Nwa surveyed before
and under CDTI MDA










South west DERF Mamfe 64.60 49.73 23.02 0.7529 0.335 2,957.8 1,934.8 34.58 < 0.0001
DHERF 59.40 71.97 -21.16 10.6411 0.001 5,800.9 5,743.6 0.99 < 0.0001
North west FS Nwa 0.20 0.50 -150.00 0.0331 0.281 13.90 175.8 -1164.74 < 0.0001
Abbreviations: DERF deciduous equatorial rainforest, DHERF dense humid equatorial rainforest, FS forested savanna, IVM MDA ivermectin mass drug administration
(χ2 test was used to compare prevalence rates before and under treatment; t-test was used to compare mean intensity of infection before and under treatment)
a b
c d
Fig. 5 Reduced prevalence of M. perstans infection following multiple rounds of IVM-MDA in Mamfe DHERF district but not in DHERF areas in the
East. a, b Prevalence of M. perstans infection in community members residing in DHERF zones prior to MDA and after at least 8 or 10 years IVM therapy.
In 2013, neither Lolodorf (n = 290) nor Batouri (n = 900) districts in eastern Cameroon had entered in MDA programmes. Messamena (n = 862) and
Bertoua (n = 561) districts, also in the East, had received at least 8 rounds of MDA and the South West district of Mamfe had had > 10 rounds MDA
(n = 1,276). Mamfe 0 refers to prevalence and intensity prior to MDA therapy (n = 640). c, d show mf counts in the different communities based on
rounds of MDA (0, 8 > 10) or per district respectively. Statistical significance of the differences between groups indicated by the brackets were
obtained after ANOVA/Kruskal-Wallis or Student's t-test/Mann-Whitney analysis depending on the normal distribution of the data
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paramount importance. This gives an opportunity to
design studies that can compare the immune responses of
children to vaccination and other pathogens in contrasting
areas of endemicity ofM. perstans.
In the east and south, a concrete comparison and con-
clusion cannot be made for Batouri, Bertoua Messamena
and Lolodorf health districts because no baseline data
exist for the communities of the bioecological zones.
Nevertheless, since the zones belong to the same eco-
logical zone (DHERF), we see that at Batouri and Lolodorf
that were not yet under CDTI (no treatment) the preva-
lence was 38.9 and 53.8 %, respectively, whereas those of
Bertoua and Messamena (with 8 years of annual IVM)
were 50.1 and 51 %, respectively. These high rates of infec-
tion in both non-treated and treated communities of the
same bioecological zone may be due to (i) low adherence
to treatment due to the presence of L. loa in these areas
and consequent fear of severe adverse events; and (ii) little
or no effect of IVM on the parasite although this will
mean that the same communities be screened at 10 and
12 years after CDTI. Just as the prevalence increased in
these zones, the intensity of infection also increased. This
is normal if the drug is not effective, these parameters
should increase with time. In the FS of Nwa health
district, although the prevalence was low, a significant
decrease was observed in the mf intensity after 8 years of
IVM MDA. The consistent low prevalence in this zone
could be due to the ecology of the area (lack of breeding
sites as well as the vector) and the lack of heavy infection
to propagate transmission, and not the fact that individ-
uals here have received up to 8 rounds of mass treatment
with ivermectin.
Comparison of DHERF zones in the east and south-
west following multiple MDA rounds revealed a decrease
in the prevalence in south-western but not in eastern
Cameroon. The observed reduction in Mamfe may be due
to: (i) better compliance in Mamfe than in Messamena
and Bertoua; (ii) that at least 10 years of IVM treatment
are required before MDA begins to have an effect on M.
perstans infections; or (iii) changes or destruction of the
forest zone in Mamfe over the last decade leading to
reduced vector breeding sites and consequent abundance.
The persistence of the infection in Messamena and
Bertoua despite 8 years of IVM MDA could be due to
poor adherence of the population to the MDA pro-
grammes as demonstrated by Wanji et al. [28].
Conclusions
This study has demonstrated that M. perstans is highly
endemic in the equatorial rainforest areas and low in
a b
c d
Fig. 6 Kumba district shows the lowest prevalence of M. perstans infection in DERF bioecological zones. a, b show prevalence and mf intensity in
M. perstans infected individuals living in DERF bioecological zones after at least 10 years of MDA therapy. Mamfe (n = 376); Tombel (n = 1,170);
Konye (n = 885); and Kumba (n = 1,241). c, d show the prevalence and mf numbers in individuals living in DERF zones that had had 0 MDA
(Mamfe; n = 404), > 4 years of MDA (Bare; n = 872) and > 10 years of MDA (Tombel, Konye, Kumba and Mamfe; n = 3,672). Statistical significance of
the differences between groups indicated by the brackets were obtained after ANOVA/Kruskal-Wallis or Student's t-test/Mann-Whitney analysis
depending on the normal distribution of the data
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savanna areas of Cameroon and this has not been
affected by long-term IVM-MDA programmes. Before
CDTI introduction, the high prevalence and intensities
of M. perstans infection were observed in both DERF
and DHERF of Mamfe. After a decade of IVM-MDA
infection levels had dropped in individuals residing in
DERF and not in DHERF communities. The decrease in
infection intensity could be either due to IVM-MDA
intervention or due to ecological changes over time that
have led to a loss of breeding sites and a consequent
decrease in the vectors’ abundance. Since it is known
that M. perstans downregulates host's immune system,
the findings from this work would be useful in designing
studies to understand the impact of M. perstans on host
immune response to vaccination and co-infection with
other pathogens such as Mycobacterium spp. and
Plasmodium spp. in areas of contrasting endemicities.
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